TOPICS
Marketing Funnel for Biotech & Pharma
DIRECT ANSWER
A marketing funnel is a framework that maps the stages a prospective buyer moves through — from first awareness of a problem through evaluation to purchase and retention. Funnels are used to identify where leads drop out, allocate budget by stage, and set conversion rate benchmarks. Most modern B2B funnels extend below the purchase to include expansion and advocacy. For Biotech & Pharma companies, this matters because Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch.
What marketing funnel means for Biotech & Pharma
The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.
For Biotech & Pharma teams the relevant marketing pains are: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute
Funnel Stages and Conversion Benchmarks
The classic AIDA model (Awareness, Interest, Desire, Action) has been extended in B2B contexts to a six-stage structure: Awareness → Interest → Consideration → Intent → Purchase → Retention/Advocacy. In practice, most marketing teams segment this into top-of-funnel (TOFU: awareness and education), middle-of-funnel (MOFU: evaluation and comparison), and bottom-of-funnel (BOFU: purchase-ready, pricing, trial). Each stage has distinct content types, channel mixes, and conversion metrics.
Conversion benchmarks vary significantly by industry and average contract value. For B2B SaaS, typical MQL-to-SQL rates run 20–40%, SQL-to-opportunity 50–70%, and opportunity-to-close 20–30%, yielding an end-to-end lead-to-customer rate of 2–8%. For high-ACV enterprise products, funnel velocity matters as much as rate — sales cycles of 90–180 days mean pipeline health is measured in months, not weeks. eCommerce funnels are much shorter but have higher abandonment at checkout (average cart abandonment rate: 70%).
Running marketing funnel for Biotech & Pharma with CoMo
CoMo's agents apply marketing funnel across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships for Biotech & Pharma companies — tuned to VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma and run under your approval, alongside every other marketing function.
FAQ
Marketing Funnel for Biotech & Pharma — common questions
What is the difference between a marketing funnel and a sales funnel?
A marketing funnel covers the buyer's journey from initial awareness through lead generation — activities owned by marketing. A sales funnel covers the portion from qualified lead through closed deal — activities owned by sales. In modern revenue operations, they are treated as one continuous pipeline with a shared handoff definition (typically the MQL-to-SQL threshold) rather than two separate processes.
How does marketing funnel differ for Biotech & Pharma companies?
The fundamentals are the same, but Biotech & Pharma marketing carries specific constraints — Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch and FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute. CoMo adapts execution to that context automatically.
BUILT BY COMO'S AGENTS
This page was written by CoMo — the autonomous CMO.
CoMo runs every channel of your marketing on your live data. See it work on your brand.